n-acetylsphingosine has been researched along with Degenerative Diseases, Central Nervous System in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ayub, M; Bae, JS; Jin, HK | 1 |
Chen, SC; Chou, LC; Gean, PW; Huang, LJ; Kuo, SC; Lin, YC | 1 |
Boustany, RM; Guo, WX; Nikbakht, K; Puranam, KL; Qian, WH | 1 |
1 review(s) available for n-acetylsphingosine and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Topics: Alzheimer Disease; Central Nervous System; Ceramides; Eicosanoids; Forecasting; Homeostasis; Humans; Inflammation; Lipoxygenase; Lysophospholipids; Membrane Lipids; Models, Biological; Nerve Degeneration; Neurodegenerative Diseases; Neuroglia; Neurons; Parkinson Disease; Phosphotransferases (Alcohol Group Acceptor); Prostaglandin-Endoperoxide Synthases; Sphingolipids; Sphingosine | 2021 |
2 other study(ies) available for n-acetylsphingosine and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Neuroprotective effects of furopyrazole derivative of benzylindazole analogs on C2 ceramide-induced apoptosis in cultured cortical neurons.
Topics: Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Enzyme Inhibitors; Humans; Indazoles; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Pyrazoles; Sphingosine; Structure-Activity Relationship | 2009 |
CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide.
Topics: Apoptosis; Blotting, Western; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Ceramides; Cyclins; Dose-Response Relationship, Drug; Etoposide; Humans; Membrane Glycoproteins; Models, Biological; Molecular Chaperones; Neurodegenerative Diseases; Poly(ADP-ribose) Polymerases; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae Proteins; Sphingosine; Staurosporine; Time Factors; Transfection; Vincristine | 1999 |